HY-137464A-10mg
|
MedChemexpress LLC
|
OATD-01 [CAS 2088453-21-6]
|
|
COVID-19-immunoregulation
|
|
HY-137464A-100mg
|
MedChemexpress LLC
|
OATD-01 [CAS 2088453-21-6]
|
|
COVID-19-immunoregulation
|
|
HY-137464A-25mg
|
MedChemexpress LLC
|
OATD-01 [CAS 2088453-21-6]
|
|
COVID-19-immunoregulation
|
|
HY-137464A-5mg
|
MedChemexpress LLC
|
OATD-01 [CAS 2088453-21-6]
|
|
COVID-19-immunoregulation
|
|
HY-137464A-50mg
|
MedChemexpress LLC
|
OATD-01 [CAS 2088453-21-6]
|
|
COVID-19-immunoregulation
|
|
HY-137464A-1mL
|
MedChemexpress LLC
|
OATD-01 [CAS 2088453-21-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-131335-10mg
|
MedChemexpress LLC
|
p38Alpha inhibitor 2 [CAS 1095003-80-7]
|
|
COVID-19-immunoregulation
|
|
HY-131335-100mg
|
MedChemexpress LLC
|
p38Alpha inhibitor 2 [CAS 1095003-80-7]
|
|
COVID-19-immunoregulation
|
|
HY-131335-25mg
|
MedChemexpress LLC
|
p38Alpha inhibitor 2 [CAS 1095003-80-7]
|
|
COVID-19-immunoregulation
|
|
HY-131335-5mg
|
MedChemexpress LLC
|
p38Alpha inhibitor 2 [CAS 1095003-80-7]
|
|
COVID-19-immunoregulation
|
|
HY-131335-50mg
|
MedChemexpress LLC
|
p38Alpha inhibitor 2 [CAS 1095003-80-7]
|
|
COVID-19-immunoregulation
|
|
HY-131335-1mL
|
MedChemexpress LLC
|
p38Alpha inhibitor 2 [CAS 1095003-80-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10844-10mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-100mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-5mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-50mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-1mL
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10844S-1mg
|
MedChemexpress LLC
|
Pretomanid-d4 [CAS 1346617-34-2]
|
|
COVID-19-immunoregulation
|
|
HY-10844S-500ug
|
MedChemexpress LLC
|
Pretomanid-d4 [CAS 1346617-34-2]
|
|
COVID-19-immunoregulation
|
|
HY-N8461-10mg
|
MedChemexpress LLC
|
Reuterin [CAS 2134-29-4]
|
|
COVID-19-immunoregulation
|
|
HY-N8461-100mg
|
MedChemexpress LLC
|
Reuterin [CAS 2134-29-4]
|
|
COVID-19-immunoregulation
|
|
HY-N8461-25mg
|
MedChemexpress LLC
|
Reuterin [CAS 2134-29-4]
|
|
COVID-19-immunoregulation
|
|
HY-N8461-5mg
|
MedChemexpress LLC
|
Reuterin [CAS 2134-29-4]
|
|
COVID-19-immunoregulation
|
|
HY-N8461-50mg
|
MedChemexpress LLC
|
Reuterin [CAS 2134-29-4]
|
|
COVID-19-immunoregulation
|
|
HY-N8461-1mL
|
MedChemexpress LLC
|
Reuterin [CAS 2134-29-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|